Neuroprotective Therapy in Parkinson's Disease: Current Status and New Directions from Experimental and Genetic Clues.
- Author:
William LIN
1
;
Un Jung KANG
Author Information
- Publication Type:Review
- Keywords: Parkinson's disease; Genetics; Pathogenesis; Neuroprotection
- MeSH: Genetics; Humans; Parkinson Disease*
- From:Journal of Clinical Neurology 2005;1(2):107-120
- CountryRepublic of Korea
- Language:English
- Abstract: Despite successful treatment of Parkinson's disease (PD) with a wide variety of symptomatic therapy, the disease continues to progress and drug-resistance symptoms become the predominant factors producing the disability of PD patients. Neuroprotective therapies have been tested, but clinically effective drugs have not been found yet. New insights gained from studies of genetic forms of PD point to the common pathogenic mechanisms that have been suspected in sporadic forms of the disease and may provide new approaches for the future neuroprotective therapies.
